KFDA to introduce fast review system for BT products next year

Published: 2006-12-21 06:58:00

Updated: 2006-12-21 06:58:00

The Korea Food and Drug Administration unveiled its plan to implement a fast review system from next year to shorten the screening period of biopharmaceutical products' safety and efficacy data from 14 months to 6 months.

The health regulator also plans to introduce another GMP standard for th...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK